Track Sanofi Consumer Healthcare India Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 0.05 %
Low
4,508.6
High
4,615.0
1 Month returns: -4.13 %
Low
4,500.0
High
4,988.8
1 Year returns: -10.96 %
Low
3,950.5
High
5,512.0
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Sanofi Consumer Healthcare India Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Sanofi Consumer Healthcare India Ltd. Shareholding Pattern
Quarterly breakdown of Sanofi Consumer Healthcare India Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Sanofi Consumer Healthcare India Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Sanofi Consumer Healthcare India Ltd.?
The current share price of Sanofi Consumer Healthcare India Ltd. is ₹ 4,567.20 as of 17 Jul 2026.
What is the market capitalisation of Sanofi Consumer Healthcare India Ltd.?
The market capitalisation of Sanofi Consumer Healthcare India Ltd. stands at ₹ 10,518.70 Cr.
What is the PE ratio of Sanofi Consumer Healthcare India Ltd.?
The Price-to-Earnings (PE) ratio of Sanofi Consumer Healthcare India Ltd. is 40.79 as of the latest trailing twelve months data.
What is the ROE and ROCE of Sanofi Consumer Healthcare India Ltd.?
Sanofi Consumer Healthcare India Ltd. has a Return on Equity (ROE) of 73.09% and a Return on Capital Employed (ROCE) of 84.69% as per the latest financial reports.
What is the 52-week high and low of Sanofi Consumer Healthcare India Ltd.?
The 52-week high of Sanofi Consumer Healthcare India Ltd. is - and the 52-week low is -.
What is the dividend yield of Sanofi Consumer Healthcare India Ltd.?
The dividend yield of Sanofi Consumer Healthcare India Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Sanofi Consumer Healthcare India Ltd.?
Foreign Institutional Investors (FII) hold 2.76%, Domestic Institutional Investors (DII) hold 17.57% and retail/public investors hold 7.61% of Sanofi Consumer Healthcare India Ltd. shares.
What sector does Sanofi Consumer Healthcare India Ltd. belong to?
Sanofi Consumer Healthcare India Ltd. operates in the Healthcare sector.
What is the beta of Sanofi Consumer Healthcare India Ltd.?
The beta of Sanofi Consumer Healthcare India Ltd. is 0.54, indicating its price volatility relative to the broader market. Over the past 1 year, Sanofi Consumer Healthcare India Ltd. has delivered an absolute return of -12.47%.
What is the RSI of Sanofi Consumer Healthcare India Ltd.?
The 14-day Relative Strength Index (RSI) of Sanofi Consumer Healthcare India Ltd. is 45.52, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Sanofi Consumer Healthcare India Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
The company delivered strong revenue growth of 36.32% for 12-month ended 31 Mar 2026 and the growth was 25.09 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 11.23
Value 36.32
-82.35114662
Strong EPS growth and above median growth of industry
The company delivered strong EPS growth of 53.24% for 12-month ended 31 Mar 2026 and the growth was 45.12 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.06 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year
What is Debt to Equity?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 40.79 indicates that the stock is expensive on a standalone basis and is at a 32.09% premium to industry median P/E
What is P/E Ratio?
Median: 30.88
Value 40.79
-44.893379.36
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
High ROE but declining trend
The company reported strong ROE of 73.09% for 12-month ended 31 Mar 2026 but ROE declined by -223 bps from 1 year ago
What is ROE (FY)?
High operating margin but declining trend
The company reported strong operating margin of 34.32% for 12-month ended 31 Mar 2026 but operating margin declined by -172 bps from 1 year ago
What is Operating profit margin?
Company's earnings are of moderate quality
Earnings quality score of 47.6 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
47.6 / 100
No red flags found!
No significant red flags found in the stock.
Company Profile
Overview of Sanofi Consumer Healthcare India Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.
Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds ...
Key personnel
Mr. Nikunjkumar Jaysukhlal Savaliya
Compliance Officer, Company Secretary
Mr. Amit JainD
Independent Chairman of the Board
Ms. Maithilee Kaizad MistryD
Chief Financial Officer, Whole-Time Director
Mr. Himanshu BakshiD
Managing Director, Whole-Time Director
Mr. Stanislas Marie Jean Paul CamartD
Non-Executive Director
Ms. Carol-Ann StewartD
Non-Executive Director
Mr. Shobinder DuggalD
Non-Executive Independent Director
Ms. Suparna PandhiD
Non-Executive Independent Director
Incorporated on
10 May 2023
Last Annual
31 Dec 2025
Last Interim
31 Mar 2026
No. of Employees
597
IPO date
13 Sep 2024
Free Float
65,73,477
Website
Phone no.
+91022280320
Address
Sanofi House, CTS No. 117-B,, L&T Business Park, Saki Vihar Road, Powai, MUMBAI, 400072, India
Holdings and Presence
Indices and prominent investors with a stake in this stock.